Counterfeiting, Compliance, and Controls

The company’s exhibitions will be focused in the areas of its pipeline, proprietary capsid engineering, and manufacturing.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

The commitment will include new, state-of-the-art R&D facilities as well as new or expanded manufacturing sites in multiple states.

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

The policy announced by Commissioner Martin A. Makary, MD, will not preclude employees of regulated companies from presenting their views to committees, and rare exceptions will be allowed.

Calculating the amount of drug needed for compounding requires different considerations for respective drug types and forms.